| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2022-10-02 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | $567.93M | – | $218.90M |
| R&D | $635.07M | $795.87M | $373.28M | $437.07M | – | $181.49M |
| SG&A | $110.31M | $89.24M | $62.77M | $130.86M | – | $37.41M |
| Operating Income | -$745.38M | -$885.11M | -$436.05M | -$567.93M | – | -$218.90M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $1.44M | $735.00K | -$1.38M | $438.00K | – | $1.37M |
| Net Income | -$738.82M | -$846.42M | -$408.17M | -$570.28M | – | -$213.80M |
| EPS (basic) | -6.8600 | -9.2800 | -5.7300 | -12.7500 | – | -5.4300 |
| EPS (diluted) | -6.8600 | -9.2800 | -5.7300 | -12.7500 | – | -5.4300 |
| Shares (diluted) | $107.62M | $91.23M | $71.20M | $44.74M | – | $39.38M |